These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8764799)

  • 61. The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo.
    Sehi M; Grewal DS; Feuer WJ; Greenfield DS
    Vision Res; 2011 Jan; 51(2):235-42. PubMed ID: 20813123
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
    Tofflemire KL; Whitley EM; Allbaugh RA; Ben-Shlomo G; Robinson CC; Overton TL; Thiessen CE; Evans EA; Griggs AN; Adelman SA; Ludwig AL; Jens JK; Ellinwood NM; Peterson CS; Whitley RD
    Am J Vet Res; 2015 Jul; 76(7):625-31. PubMed ID: 26111092
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma.
    McKibbin M; Menage MJ
    Eye (Lond); 1999; 13 ( Pt 1)():31-4. PubMed ID: 10396380
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.
    Manni G; Centofanti M; Parravano M; Oddone F; Bucci MG
    Graefes Arch Clin Exp Ophthalmol; 2004 Sep; 242(9):767-70. PubMed ID: 15241611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study.
    Larsson LI
    Acta Ophthalmol Scand; 2001 Dec; 79(6):567-71. PubMed ID: 11782220
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF; Hubatsch DA; Amaris P
    BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma.
    Drance SM; Crichton A; Mills RP
    Am J Ophthalmol; 1998 May; 125(5):585-92. PubMed ID: 9625541
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of pilocarpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E2 0.1% on intraocular pressure in laser-induced glaucomatous monkey eyes.
    Serle JB; Wang RF; Mittag TW; Shen F; Podos SM
    J Glaucoma; 2001 Jun; 10(3):215-9. PubMed ID: 11442186
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The combination latanoprost-timolol versus twice daily 0.50% timolol administration either associated or not with latanoprost: efficacy and tolerability in the primary open-angle glaucoma.
    Pacella E; Pacella F; Cavallotti C; Librando A; Feher J; Pecori-Giraldi J
    Eur Rev Med Pharmacol Sci; 2010 May; 14(5):477-80. PubMed ID: 20556928
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure.
    Jampel HD; Bacharach J; Sheu WP; Wohl LG; Solish AM; Christie W;
    Am J Ophthalmol; 2002 Dec; 134(6):863-71. PubMed ID: 12470755
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.
    Aung T; Chew PT; Oen FT; Chan YH; Thean LH; Yip L; Lim BA; Soh J; Seah SK
    Br J Ophthalmol; 2002 Jan; 86(1):75-9. PubMed ID: 11801508
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical experience in the treatment of normal tension glaucoma with latanoprost in Germany.
    Thelen U; Weiler W; Kirchhoff E; Fuchs HB; Stewart WC
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):311-3. PubMed ID: 17593016
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of the fixed combination of latanoprost and timolol with its individual components.
    Pfeiffer N;
    Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):893-9. PubMed ID: 12486510
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of latanoprost on intraocular pressure following cataract extraction.
    Scherer WJ; Mielke DL; Tidwell PE; Hauber FA
    J Cataract Refract Surg; 1998 Jul; 24(7):964-7. PubMed ID: 9682119
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Twenty-four-hour ocular hypotensive effects of 0.0015% tafluprost and 0.005% latanoprost in healthy subjects.
    Mochizuki H; Itakura H; Yokoyama T; Takamatsu M; Kiuchi Y
    Jpn J Ophthalmol; 2010 Jul; 54(4):286-90. PubMed ID: 20700794
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety and efficacy of topically administered netarsudil-latanoprost fixed dose combination (FDC; Rocklatan™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).
    Leary KA; Steibel JP; Harman CD; Anderson AL; Komáromy AM
    Vet Ophthalmol; 2021 Nov; 24(6):610-619. PubMed ID: 34085750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Additive effect of bunazosin on intraocular pressure when topically added to treatment with latanoprost in patients with glaucoma.
    Tsukamoto H; Jian K; Takamatsu M; Okada K; Mukai S; Tsumamoto Y; Mishima HK
    Jpn J Ophthalmol; 2003; 47(5):526-8. PubMed ID: 12967873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.